Recalls & Warnings August 30, 2012 FDA Warns of Medical Claims Made For Numerous Chinese Herbal Products On August 15, 2012, the FDA warned Dragon Herbs that promotional statements made on the company's website constitute drug claims for twenty herbal products, including CardioPro 2000, Cordyceps, Duanwood Reishi, Gynostemma, Ginseng and Astragalus Combination, Dang Gui and Gelatin, Sweet Relief,
[7] The risk is higher with alcoholic or acetonic extracts, or concentrated forms like pills
Specifically, we stated that we believe the attestation requirement we proposed would not only incorporate those concepts, but, in fact, would mandate significantly heightened hospital recognition of their responsibilities than what we presently require
However, the direct administration of GSH is rare in myocardial injury treatment studies
Enhanced Blood Flow: Promotes angiogenesis in damaged intestinal tissue, delivering oxygen and nutrients to support repair
This article also focuses on bpc 157 for recovery as a key part of mobile IV therapy in Las Vegas and related recovery options